Bulk Manufacturer of Controlled Substances Registration, 56103 [2018-24484]
Download as PDF
<![CDATA[
56103
Federal Register / Vol. 83, No. 218 / Friday, November 9, 2018 / Notices
On March 27, 2012, 3D PDF filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on April 20, 2012 (77 FR 23754).
The last notification was filed with
the Department on August 15, 2018. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on September 4, 2018 (83 FR
44904).
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2018–24542 Filed 11–8–18; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as bulk manufacturer of
various basic classes of controlled
substances. Information on the
previously published notice is listed in
the table below. No comments or
objections were submitted for this
notice.
SUMMARY:
Company
FR citation
Euticals Inc ...
83 FR 39129
Published
August 8,
2018.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
Dated: October 29, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–24484 Filed 11–8–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Chattem
Chemicals
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 8, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated
his authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on August
2, 2018, Chattem Chemicals, 3801 Saint
Elmo Avenue, Chattanooga, Tennessee
37409–1237 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
khammond on DSK30JT082PROD with NOTICES
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...................................................................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................
Dihydromorphine .....................................................................................................................................................
Amphetamine ..........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Lisdexamfetamine ...................................................................................................................................................
Methylphenidate ......................................................................................................................................................
Codeine ...................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ..............................................................................................................................................................
Hydromorphone .......................................................................................................................................................
Hydrocodone ...........................................................................................................................................................
Levorphanol .............................................................................................................................................................
Methadone ...............................................................................................................................................................
Methadone intermediate ..........................................................................................................................................
Morphine ..................................................................................................................................................................
Oripavine .................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Noroxymorphone .....................................................................................................................................................
VerDate Sep<11>2014
17:36 Nov 08, 2018
Jkt 247001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
E:\FR\FM\09NON1.SGM
09NON1
2010
7360
7370
7411
9145
1100
1105
1205
1724
9050
9120
9143
9150
9193
9220
9250
9254
9300
9330
9333
9652
9668
Schedule
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 83, Number 218 (Friday, November 9, 2018)]
[Notices]
[Page 56103]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24484]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and been granted
registration by the Drug Enforcement Administration (DEA) as a bulk
manufacturer of various classes of schedule I and II controlled
substances.
SUPPLEMENTARY INFORMATION: The company listed below applied to be
registered as bulk manufacturer of various basic classes of controlled
substances. Information on the previously published notice is listed in
the table below. No comments or objections were submitted for this
notice.
------------------------------------------------------------------------
Company FR citation Published
------------------------------------------------------------------------
Euticals Inc.................... 83 FR 39129....... August 8, 2018.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of this registrant to manufacture the
applicable basic classes of controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed company.
Dated: October 29, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-24484 Filed 11-8-18; 8:45 am]
BILLING CODE 4410-09-P
